home All News open_in_new Full Article

COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year

TORONTO, ONTARIO, March 19, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announced that there is a potential for delay in the filing of: (a) its annual financial statements as […]



COSCIENS Biopharma Inc. (NASDAQ:CSCI, TSX:CSCI) announced a possible delay in filing its year-end reporting documents, including financial statements, CEO/CFO certifications, and annual information form, beyond the March 31, 2025 deadline due to complexities arising from the 2024 merger with Ceapro Inc. and identified material weaknesses in its financial controls. The company has applied for a management cease trade order and is working with auditors to complete the filings as soon as possible.

today 17 h. ago attach_file Other

attach_file Other
attach_file Transport
attach_file Other
attach_file Other
attach_file Culture
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Culture
attach_file Sport
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Other
attach_file Culture
attach_file Economics
attach_file Other


ID: 144653722
Add Watch Country

arrow_drop_down